|
Pharmaceutical Products – Contract Announcement - Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V For Various Medicinal Products (Unallocated Subject Lots 29Th Generic Tender). Amilorid + Hydrochlorothiazid (C03ea41),Calcipotriol (Loe) - D05ax02,Ciclopirox (Vcr) - G01ax12,Clindamycin (Ilo) - J01ff01,Dexamethason 0,5 Mg / Pipette - S01ba01,Dexamethason+ Gentamycin Kpg - S01ca21,Diclofenac (Gel, Except 3%) - M02aa15,Diclofenac (Hard Capsules) - M01ab05,Diclofenac (Patch) - M02aa15,Esomeprazol (20 Mg, 7 St, 14 St.) - A02bc05,Estriol (Vcr, 0,5 Mg)- G03cd01,Fentanyl (Pft, Note Specifications*) - N02ab03,Fusidic Acid (Sal) - D06ax01,Gentamicin (Cre),Glyceroltrinitrat (Lov) - C01da02,Haloperidol (Ilo) - N05ad01,Levodopa + Benserazide (Rek) - N04ba11,Ciclopirox (Vsu) - G01ax12,Levothyroxine + Kaliumiodid - H03aa51,Mesalazine (Gmr; Mrg) - A07ec02,Metoprolol + Hydrochlorothiazid (Ret) - C07bb22,Midazolam (Ilo) - N05cd08,Morphin (Bta) - N02aa01,Morphine (Ilo; Morphine Hydrochloride-3-Water, 10 Mg + 20 Mg) - N02aa01,Ofloxacin (Fta) - J01ma01,Paliperidon (175 Mg, 263 Mg, 350 Mg, 525 Mg) - N05ax13,Promethazin (Ilo) - R06ad02,Promethazin (Tei) - N05cm22,Rivastigmine (Lse) - N06da03,Tacrolimus (0,3 Mg, Sal) - D11ah01,Tramadol (131,76 Mg; 175,68 Mg - 10 St.; Ret) - N02ax02,Triamcinolon Acetonid (Amp) - H02ab58,Triamcinolon Acetonid (Sal) - D07ab09,Ceftriaxon (Plf) - J01dd04,Valproic Acid (Ret) - N03ag01,Ciclopirox (Naw) - D01ae14,Lacosamide (Inf) - N03ax18
|
